| Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis KS Cheung, IFN Hung, PPY Chan, KC Lung, E Tso, R Liu, YY Ng, ... Gastroenterology 159 (1), 81-95, 2020 | 1974 | 2020 |
| Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong, WK Leung Gut 67 (1), 28-35, 2018 | 479 | 2018 |
| Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management KS Cheung, WK Leung World journal of gastroenterology 23 (11), 1954, 2017 | 256 | 2017 |
| hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection LY Mak, DKH Wong, KS Cheung, WK Seto, CL Lai, MF Yuen Alimentary pharmacology & therapeutics 47 (1), 43-54, 2018 | 226 | 2018 |
| Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA DKH Wong, WK Seto, KS Cheung, CK Chong, FY Huang, J Fung, CL Lai, ... Liver International 37 (7), 995-1001, 2017 | 195 | 2017 |
| Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals WK Leung, IOL Wong, KS Cheung, KF Yeung, EW Chan, AYS Wong, ... Gastroenterology 155 (1), 67-75, 2018 | 148 | 2018 |
| Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A (H3N2) infection: an open-label randomized, controlled … IFN Hung, KKW To, JFW Chan, VCC Cheng, KSH Liu, A Tam, TC Chan, ... Chest 151 (5), 1069-1080, 2017 | 124 | 2017 |
| Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence KS Cheung, WK Leung Therapeutic advances in gastroenterology 12, 1756284819834511, 2019 | 114 | 2019 |
| Inverse relationship between hepatic steatosis and hepatitis B viremia: results of a large case‐control study RWH Hui, WK Seto, KS Cheung, LY Mak, KSH Liu, J Fung, DKH Wong, ... Journal of viral hepatitis 25 (1), 97-104, 2018 | 114 | 2018 |
| Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B WK Seto, RWH Hui, LY Mak, J Fung, KS Cheung, KSH Liu, DKH Wong, ... Clinical Gastroenterology and Hepatology 16 (4), 575-583. e2, 2018 | 113 | 2018 |
| Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B LY Mak, RWH Hui, J Fung, F Liu, DKH Wong, KS Cheung, MF Yuen, ... Journal of hepatology 73 (4), 800-806, 2020 | 109 | 2020 |
| Seven-year treatment outcome of entecavir in a real-world cohort: effects on clinical parameters, HBsAg and HBcrAg levels YF Lam, WK Seto, D Wong, KS Cheung, J Fung, LY Mak, J Yuen, ... Clinical and translational gastroenterology 8 (10), e125, 2017 | 106 | 2017 |
| Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: a prospective study WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ... Hepatology 65 (5), 1451-1461, 2017 | 103 | 2017 |
| Association of hepatitis B core-related antigen with hepatitis B virus reactivation in occult viral carriers undergoing high-risk immunosuppressive therapy WK Seto, DKH Wong, TSY Chan, YY Hwang, J Fung, KSH Liu, H Gill, ... Official journal of the American College of Gastroenterology| ACG 111 (12 …, 2016 | 93 | 2016 |
| Tenofovir versus entecavir for hepatocellular carcinoma prevention in an international consortium of chronic hepatitis B YC Hsu, GLH Wong, CH Chen, CY Peng, ML Yeh, KS Cheung, H Toyoda, ... Official journal of the American College of Gastroenterology| ACG 115 (2 …, 2020 | 87 | 2020 |
| Relationship between HB sAg, HB crAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos (t) ide therapy KS Cheung, WK Seto, DKH Wong, CL Lai, MF Yuen Journal of Viral Hepatitis 24 (8), 654-661, 2017 | 85 | 2017 |
| Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation WK Seto, KSH Liu, LY Mak, G Cloherty, DKH Wong, J Gersch, YF Lam, ... Gut 70 (4), 775-783, 2021 | 84 | 2021 |
| Risk of gastric cancer development after eradication of Helicobacter pylori KS Cheung, WK Leung World journal of gastrointestinal oncology 10 (5), 115, 2018 | 79 | 2018 |
| Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated … HI Yang, ML Yeh, GL Wong, CY Peng, CH Chen, HN Trinh, KS Cheung, ... The Journal of infectious diseases 221 (3), 389-399, 2020 | 78 | 2020 |
| Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication KS Cheung, EW Chan, AYS Wong, L Chen, WK Seto, ICK Wong, ... JNCI: Journal of the National Cancer Institute 111 (5), 484-489, 2019 | 69 | 2019 |
